AI: Show Me the Outcomes - Report - MDSpire

AI: Show Me the Outcomes

  • By

  • kffconnorg

  • June 30, 2026

  • 0 min

Share

Clinical Report: AI: Demonstrating Clinical Outcomes

Overview

Dr. Toyin Ajayi discusses the allocation of AI investments in healthcare, noting that a significant portion is directed towards billing and coding.

Background

The integration of artificial intelligence (AI) in healthcare is critical as it has the potential to transform care delivery. Current investments in AI predominantly focus on administrative tasks.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

  • Approximately 60% of healthcare AI investment is allocated to billing and coding.
  • Cityblock Health serves over 100,000 Medicaid and dual-eligible members across ten states.

Clinical Implications

Healthcare professionals should consider the implications of AI investments.

Conclusion

The conversation highlights the importance of AI investments in healthcare.

Related Resources & Content

  1. Ajayi T., The Business of Health with Chip Kahn, 2026 -- AI: Show Me the Outcomes
  2. npj Digital Medicine — AI and innovation in clinical trials
  3. The ASCO Post — Novel AI Platform May Help Identify Patients Likely to Benefit Most From Clinical Trials
  4. Journal of Medical Internet Research (JMIR) — AI in Clinical Decision Support Systems: Promising Applications and Strategies for Managing Data Challenges
  5. asco ai in oncology — Clinical Staff Using Natural Language Processing Model Enhances Accuracy of Clinical Trial Prescreening Process
  6. AI and innovation in clinical trials
  7. Novel AI Platform May Help Identify Patients Likely to Benefit Most From Clinical Trials
  8. AI in Clinical Decision Support Systems: Promising Applications and Strategies for Managing Data Challenges
  9. Ethics and governance of artificial intelligence for health: large multi-modal models. WHO guidance
  10. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening | Nature Medicine
  11. Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial - PMC

Original Source(s)

Related Content